Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results
No. 3 / 2025Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results ...
Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial Results
Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...
MM&M1d
How new direct-to-consumer platforms are changing pharma’s relationships with patients
New DTC platforms like LillyDirect and PfizerForAll are triggering a paradigm shift in how pharma companies connect with patients.
Packaging World1d
Automation Unscrambles Bottling Chaos
Pace Packaging harnessed flexible automation in a versatile robotic unscrambling and orienting solution that delivers ...
Researcher ICON Sued by Investor Over Revenue Miss Stock Dive
Clinical research conductor ICON Plc downplayed impacts from demand softness from the pharmaceutical and biotechnology industries, surprising investors with a $100 million revenue shortfall that led ...